ID NAA15_MOUSE Reviewed; 865 AA. AC Q80UM3; Q811Z9; Q9JID5; DT 04-JAN-2005, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2003, sequence version 1. DT 24-JAN-2024, entry version 152. DE RecName: Full=N-alpha-acetyltransferase 15, NatA auxiliary subunit; DE AltName: Full=N-terminal acetyltransferase 1; DE AltName: Full=NMDA receptor-regulated protein 1; DE AltName: Full=Protein tubedown-1; GN Name=Naa15; Synonyms=Narg1, Nat1, Tbdn-1, Tubedown; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH XRCC6 AND XRCC5, SUBCELLULAR RP LOCATION, TISSUE SPECIFICITY, AND FUNCTION. RC TISSUE=Heart; RX PubMed=12145306; DOI=10.1074/jbc.m206482200; RA Willis D.M., Loewy A.P., Charlton-Kachigian N., Shao J.-S., Ornitz D.M., RA Towler D.A.; RT "Regulation of osteocalcin gene expression by a novel Ku antigen RT transcription factor complex."; RL J. Biol. Chem. 277:37280-37291(2002). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, IDENTIFICATION IN THE N-TERMINAL RP ACETYLTRANSFERASE A COMPLEX, INTERACTION WITH NAA10, SUBCELLULAR LOCATION, RP AND TISSUE SPECIFICITY. RC TISSUE=Testis; RX PubMed=12888564; DOI=10.1074/jbc.m301218200; RA Sugiura N., Adams S.M., Corriveau R.A.; RT "An evolutionarily conserved N-terminal acetyltransferase complex RT associated with neuronal development."; RL J. Biol. Chem. 278:40113-40120(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=ICR; TISSUE=Trophoblast stem cell; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 158-865, CHARACTERIZATION, ACETYLATION, AND RP FUNCTION. RC STRAIN=ICR; TISSUE=Embryo; RX PubMed=10842358; RX DOI=10.1002/(sici)1097-0177(200006)218:2<300::aid-dvdy5>3.0.co;2-k; RA Gendron R.L., Adams L.C., Paradis H.; RT "Tubedown-1, a novel acetyltransferase associated with blood vessel RT development."; RL Dev. Dyn. 218:300-315(2000). RN [5] RP IDENTIFICATION, INDUCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE. RX PubMed=11297529; DOI=10.1074/jbc.m100011200; RA Sugiura N., Patel R.G., Corriveau R.A.; RT "N-methyl-D-aspartate receptors regulate a group of transiently expressed RT genes in the developing brain."; RL J. Biol. Chem. 276:14257-14263(2001). RN [6] RP FUNCTION. RX PubMed=15452080; DOI=10.1167/iovs.03-1410; RA Wall D.S., Gendron R.L., Good W.V., Miskiewicz E., Woodland M., Leblanc K., RA Paradis H.; RT "Conditional knockdown of tubedown-1 in endothelial cells leads to RT neovascular retinopathy."; RL Invest. Ophthalmol. Vis. Sci. 45:3704-3712(2004). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-854 AND SER-855, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=17242355; DOI=10.1073/pnas.0609836104; RA Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; RT "Large-scale phosphorylation analysis of mouse liver."; RL Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-854, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, RC Pancreas, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Auxillary subunit of N-terminal acetyltransferase complexes CC which display alpha (N-terminal) acetyltransferase (NAT) activity. The CC NAT activity may be important for vascular, hematopoietic and neuronal CC growth and development. Required to control retinal neovascularization CC in adult ocular endothelial cells. In complex with XRCC6 and XRCC5 CC (Ku80), up-regulates transcription from the osteocalcin promoter. CC {ECO:0000269|PubMed:10842358, ECO:0000269|PubMed:12145306, CC ECO:0000269|PubMed:12888564, ECO:0000269|PubMed:15452080}. CC -!- SUBUNIT: Component of the N-terminal acetyltransferase A complex (also CC called the NatA complex) composed of NAA10 and NAA15 (PubMed:12888564). CC Within the complex interacts with NAA10 (PubMed:12888564). Component of CC the N-terminal acetyltransferase A (NatA)/HYPK complex at least CC composed of NAA10, NAA15 and HYPK, which has N-terminal CC acetyltransferase activity (By similarity). In complex with NAA10, CC interacts with HYPK (By similarity). Component of the N-terminal CC acetyltransferase E (NatE) complex at least composed of NAA10, NAA15 CC and NAA50 (By similarity). Within the complex interacts with NAA10; the CC interaction is required for binding to NAA50 (By similarity). Interacts CC with NAAT50 (By similarity). The interaction of the NatA complex with CC NAA50 reduces the acetylation activity of the NatA complex (By CC similarity). Component of the N-terminal acetyltransferase E CC (NatE)/HYPK complex at least composed of NAA10, NAA15, NAA50 and HYPK CC (By similarity). In complex with NAA10 interacts with HYPK; the CC interaction with HYPK reduces the capacity of the NatA complex to CC interact with NAA50 (By similarity). Interacts with NAA11 (By CC similarity). Interacts with XRCC6 and XRCC5 (PubMed:12145306). CC {ECO:0000250|UniProtKB:Q9BXJ9, ECO:0000269|PubMed:12145306, CC ECO:0000269|PubMed:12888564}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. CC Cytoplasm, perinuclear region {ECO:0000250}. Note=Mainly cytoplasmic, CC nuclear in some cases. Present in the free cytosolic and cytoskeleton- CC bound polysomes, but not in the membrane-bound polysomes. CC {ECO:0000250}. CC -!- TISSUE SPECIFICITY: Endothelial cells, osteoblasts and myeloid cells of CC the hematopoietic tissue. Present in adult ovary, bone marrow, brain, CC heart, kidney, testis and osteoblasts. {ECO:0000269|PubMed:11297529, CC ECO:0000269|PubMed:12145306, ECO:0000269|PubMed:12888564}. CC -!- DEVELOPMENTAL STAGE: Highly expressed in endothelial cells during CC embryonic vasculogenesis, and then down-regulated and restricted to CC specific endothelial cells. In the brain, expression is highest in CC regions that contain dividing and proliferating cells. As brain CC development progresses, expression restricts to the hippocampus and CC cerebellar cortex. {ECO:0000269|PubMed:11297529}. CC -!- INDUCTION: Regulated by NMDA receptor. {ECO:0000269|PubMed:11297529}. CC -!- PTM: Acetylated. {ECO:0000269|PubMed:10842358}. CC -!- PTM: Cleaved by caspases during apoptosis. {ECO:0000250}. CC -!- SEQUENCE CAUTION: CC Sequence=AAF73953.2; Type=Frameshift; Evidence={ECO:0000305}; CC Sequence=AAF73953.2; Type=Miscellaneous discrepancy; Note=Contaminating sequence.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF510858; AAO33713.1; -; mRNA. DR EMBL; BC050017; AAH50017.1; -; mRNA. DR EMBL; AF237622; AAF73953.2; ALT_SEQ; mRNA. DR CCDS; CCDS17340.1; -. DR AlphaFoldDB; Q80UM3; -. DR SMR; Q80UM3; -. DR IntAct; Q80UM3; 6. DR MINT; Q80UM3; -. DR STRING; 10090.ENSMUSP00000029303; -. DR GlyGen; Q80UM3; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q80UM3; -. DR PhosphoSitePlus; Q80UM3; -. DR SwissPalm; Q80UM3; -. DR EPD; Q80UM3; -. DR MaxQB; Q80UM3; -. DR PaxDb; 10090-ENSMUSP00000029303; -. DR PeptideAtlas; Q80UM3; -. DR ProteomicsDB; 252637; -. DR Pumba; Q80UM3; -. DR AGR; MGI:1922088; -. DR MGI; MGI:1922088; Naa15. DR eggNOG; KOG1156; Eukaryota. DR InParanoid; Q80UM3; -. DR PhylomeDB; Q80UM3; -. DR ChiTaRS; Naa15; mouse. DR PRO; PR:Q80UM3; -. DR Proteomes; UP000000589; Unplaced. DR RNAct; Q80UM3; Protein. DR GO; GO:0005737; C:cytoplasm; IDA:MGI. DR GO; GO:0005829; C:cytosol; ISO:MGI. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI. DR GO; GO:0031415; C:NatA complex; ISO:MGI. DR GO; GO:0016604; C:nuclear body; ISO:MGI. DR GO; GO:0005634; C:nucleus; ISO:MGI. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005667; C:transcription regulator complex; ISO:MGI. DR GO; GO:0008080; F:N-acetyltransferase activity; IDA:MGI. DR GO; GO:0043022; F:ribosome binding; ISO:MGI. DR GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW. DR GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW. DR GO; GO:0043066; P:negative regulation of apoptotic process; ISO:MGI. DR GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:MGI. DR GO; GO:0050821; P:protein stabilization; ISO:MGI. DR Gene3D; 1.25.40.1010; -; 1. DR Gene3D; 1.25.40.1040; -; 1. DR InterPro; IPR021183; NatA_aux_su. DR InterPro; IPR011990; TPR-like_helical_dom_sf. DR InterPro; IPR019734; TPR_repeat. DR PANTHER; PTHR22767:SF6; N-ALPHA-ACETYLTRANSFERASE 15, NATA AUXILIARY SUBUNIT; 1. DR PANTHER; PTHR22767; N-TERMINAL ACETYLTRANSFERASE-RELATED; 1. DR Pfam; PF12569; NatA_aux_su; 1. DR Pfam; PF13181; TPR_8; 1. DR PIRSF; PIRSF000422; N-terminal-AcTrfase-A_aux_su; 1. DR SMART; SM00028; TPR; 5. DR SUPFAM; SSF48452; TPR-like; 1. DR PROSITE; PS50005; TPR; 5. DR PROSITE; PS50293; TPR_REGION; 2. PE 1: Evidence at protein level; KW Acetylation; Angiogenesis; Cytoplasm; Developmental protein; KW Differentiation; Nucleus; Phosphoprotein; Reference proteome; Repeat; KW TPR repeat; Transcription; Transcription regulation. FT CHAIN 1..865 FT /note="N-alpha-acetyltransferase 15, NatA auxiliary FT subunit" FT /id="PRO_0000106295" FT REPEAT 46..79 FT /note="TPR 1" FT REPEAT 80..113 FT /note="TPR 2" FT REPEAT 148..184 FT /note="TPR 3" FT REPEAT 224..257 FT /note="TPR 4" FT REPEAT 374..407 FT /note="TPR 5" FT REPEAT 409..441 FT /note="TPR 6" FT REPEAT 485..518 FT /note="TPR 7" FT REPEAT 672..705 FT /note="TPR 8" FT REPEAT 799..834 FT /note="TPR 9" FT REGION 500..865 FT /note="Interaction with HYPK" FT /evidence="ECO:0000250" FT REGION 575..642 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 612..629 FT /note="Bipartite nuclear localization signal" FT /evidence="ECO:0000255" FT MOD_RES 262 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q9BXJ9" FT MOD_RES 302 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9BXJ9" FT MOD_RES 537 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9BXJ9" FT MOD_RES 588 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9BXJ9" FT MOD_RES 734 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q9BXJ9" FT MOD_RES 755 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q9BXJ9" FT MOD_RES 854 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17242355, FT ECO:0007744|PubMed:21183079" FT MOD_RES 855 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17242355" FT CONFLICT 256 FT /note="G -> E (in Ref. 2 and 4)" FT /evidence="ECO:0000305" FT CONFLICT 295 FT /note="R -> K (in Ref. 2 and 4)" FT /evidence="ECO:0000305" FT CONFLICT 452 FT /note="V -> M (in Ref. 2 and 4)" FT /evidence="ECO:0000305" FT CONFLICT 620 FT /note="Q -> P (in Ref. 4; AAF73953)" FT /evidence="ECO:0000305" FT CONFLICT 624 FT /note="Q -> P (in Ref. 4; AAF73953)" FT /evidence="ECO:0000305" FT CONFLICT 704 FT /note="G -> S (in Ref. 2 and 4)" FT /evidence="ECO:0000305" FT CONFLICT 814 FT /note="G -> R (in Ref. 4; AAF73953)" FT /evidence="ECO:0000305" SQ SEQUENCE 865 AA; 100961 MW; 230C5B6EE8697440 CRC64; MPAVSLPPKE NALFKRILRC YEHKQYRNGL KFCKQILSNP KFAEHGETLA MKGLTLNCLG KKEEAYELVR RGLRNDLKSH VCWHVYGLLQ RSDKKYDEAI KCYRNALKWD KDNLQILRDL SLLQIQMRDL EGYRETRYQL LQLRPAQRAS WIGYAIAYHL LEDYEMAAKI LEEFRKTQQT SPDKVDYEYS ELLLYQNQVL REAGLYREAL EHLCTYEKQI CDKLAVEETK GELLLQLCRL EDAADVYRGL QERNPGNWAY YKGLEKALKP ANMLERLKIY EEAWTKYPRG LVPRRLPLNF LSGEKFKECL DRFLRMNFSK GCPPVFNTLR SLYRDKEKVA IVEELVVGYE TSLKSCRLFN PNDDGKEEPP TTLLWVQYYL AQHYDKIGQP SIALEYINTA IESTPTLIEL FLVKAKIYKH AGNIKEAARW MDEAQALDTA DRFINSKCAK YVLKANLIKE AEEMCSKFTR EGTSAVENLN EMQCMWFQTE CAQAYKAMNK FGEALKKCHE IERHFIEITD DQFDFHTYCM RKITLRSYVD LLKLEDVLRQ HPFYFKAARI AIEIYLKLHD NPLTDENKEH EADTANMSDK ELKKLRNKQR RAQKKAQIEE EKKNAEKEKQ QRNQKKKKDD DDEEIGGPKE ELIPEKLAKV ETPLEEAIKF LTPLKNLVKN KIETHLFAFE IYFRKEKFLL MLQSVKRAFA IDSGHPWLHE CMIRLFHSVC ESKDLPETVR TVLKQEMNRL FGATNPKNFN ETFLKRNSDS LPHRLSAAKM VYYLDSSSQK RAIELATTLD GSLTNRNLQT CMEVLEALCD GSLGDCKEAA EAYRASCHKL FPYALAFMPP GYEEDMKITV NGDSSAETEE LANEI //